healthcare investment portal - d1luhn51essjf9.cloudfront.net · healthcare investment portal...

14
Healthcare Investment Portal Capitalizing Breakthrough Innovations Accredited investors lack access to the most compelling biomedical innovations Promising healthcare opportunities are underfunded Our Approach Invite knowledgeable, accredited investors into a portfolio of select biomedical financings Share our expertise & disclose the risks involved Make sure our incentives are aligned

Upload: phungkhuong

Post on 07-Aug-2019

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Healthcare Investment Portal - d1luhn51essjf9.cloudfront.net · Healthcare Investment Portal Capitalizing Breakthrough Innovations Accredited investors lack access to the most compelling

Healthcare Investment Portal

Capitalizing Breakthrough Innovations Accredited investors lack access to the most compelling biomedical innovations Promising healthcare opportunities are underfunded

Our Approach  Invite knowledgeable, accredited investors into a portfolio of select biomedical financings Share our expertise & disclose the risks involvedMake sure our incentives are aligned 

Page 2: Healthcare Investment Portal - d1luhn51essjf9.cloudfront.net · Healthcare Investment Portal Capitalizing Breakthrough Innovations Accredited investors lack access to the most compelling

Founded by Entrepreneurs/VCs

• Mir Imran – Prolific innovator: implantable defibrillator, embolic protection, 

cardiac ablation, etc.– His companies have generated >$200B in revenues– Owns and runs InCube Labs; co‐founded InCube Ventures

• Andrew Farquharson – Investor & entrepreneur: research executive at Genentech, built 

and sold Operon for $150M, led biomed investing for Halo Funds– Co‐founded InCube Ventures, Harvard MBA

• Talat Imran – Investor and internet entrepreneur: founder of Venture Web 

Partners & PhamFatale, analyzed investments for Halo Funds

2

Page 3: Healthcare Investment Portal - d1luhn51essjf9.cloudfront.net · Healthcare Investment Portal Capitalizing Breakthrough Innovations Accredited investors lack access to the most compelling

Mir & Team: Track Record

• Disruptive innovations, large unmet clinical needs

3

VidamedVentritexSfc GenesisSafeviewReflowPhysiometrixPercusurgeOperonMDI SourceIntellaIntecHTADataTrakCardiac PthwyCytometrix

Return to Preferred

BPH (Prostate)Heart deathBiomimeticsSecurityCoronaryBrain mappingEmbolic shieldGenomicsInternetCoronaryHeart deathReimbursementSecurityHeart ablationOncology

$1,794MReturned

$386MInvested

Company Market

1,000+5,000+

0300+500+500+700+500+0

200+6,000+1,000+800+1,000+200+

1,500+6,500+

0100+250+900+800+400

180+$8,000+N/A

1,100+N/A40+

Jobs Created Peak Revenue ($M)

Page 4: Healthcare Investment Portal - d1luhn51essjf9.cloudfront.net · Healthcare Investment Portal Capitalizing Breakthrough Innovations Accredited investors lack access to the most compelling

How We Got Here

• InCube’s investments have consistently attracted co‐investment interest – from venture firms, LPs and knowledgeable, wealthy individuals

• Two years ago, we allowed a carefully screened group of accredited investors to participate in our syndicates

• With the passage of the JOBS Act, we expanded opportunities for co‐investment via an online portal

4

Page 5: Healthcare Investment Portal - d1luhn51essjf9.cloudfront.net · Healthcare Investment Portal Capitalizing Breakthrough Innovations Accredited investors lack access to the most compelling

Business Model

• VH has adopted a carried‐interest model, typical of venture capital firms

– 20% of net profits

– Incentives aligned around quality of deal flow

• Investments flow through a Limited Partnership fund

• No fees to companies that we list on our portal

5

Page 6: Healthcare Investment Portal - d1luhn51essjf9.cloudfront.net · Healthcare Investment Portal Capitalizing Breakthrough Innovations Accredited investors lack access to the most compelling

• Investment access to disruptive innovations that are traditionally reserved for venture firms

• Invest alongside VCs, on the same terms

• Vetted by InCube Ventures

Benefits For Investors

6

Page 7: Healthcare Investment Portal - d1luhn51essjf9.cloudfront.net · Healthcare Investment Portal Capitalizing Breakthrough Innovations Accredited investors lack access to the most compelling

What Do Investors Actually Own?

• Investors purchase an ownership interest in a special‐purpose venture capital fund that acquires stock or convertible notes in one or more private companies

• Upon a liquidity event, such as an acquisition or IPO, investors receive their portion of the proceeds when they become available 

7

Page 8: Healthcare Investment Portal - d1luhn51essjf9.cloudfront.net · Healthcare Investment Portal Capitalizing Breakthrough Innovations Accredited investors lack access to the most compelling

Our Portal: www.venturehealth.com

8

Page 9: Healthcare Investment Portal - d1luhn51essjf9.cloudfront.net · Healthcare Investment Portal Capitalizing Breakthrough Innovations Accredited investors lack access to the most compelling

What We Are Looking For

• Major clinical breakthrough in a large market• Thoughtful clinical/regulatory strategy• Reimbursement is well understood• Vetted by InCube’s rigorous diligence process

9

Page 10: Healthcare Investment Portal - d1luhn51essjf9.cloudfront.net · Healthcare Investment Portal Capitalizing Breakthrough Innovations Accredited investors lack access to the most compelling

Recent Exits: > $700M in total

• Bodymedia– Acquired by Jawbone April 30, 2013

• Nfocus– Acquired by Covidien February 19, 2013

• Spinal Modulation – Equity Financing & Structured Merger with St. Jude Medical June 7, 2013

10

Page 11: Healthcare Investment Portal - d1luhn51essjf9.cloudfront.net · Healthcare Investment Portal Capitalizing Breakthrough Innovations Accredited investors lack access to the most compelling

Recent Financings On Our Portal

• Channel Medsystems, Series B– Cryo‐ablation for endometriosis– Raised $875,000 on April 16, 2013– Co‐investors: Aperture and InCube Ventures

• Rani Therapeutics, Series B– Makes injectable drugs orally available– Raised $2,490,000 on August 9, 2013– Co‐investors: Google and InCube Ventures

11

Page 12: Healthcare Investment Portal - d1luhn51essjf9.cloudfront.net · Healthcare Investment Portal Capitalizing Breakthrough Innovations Accredited investors lack access to the most compelling

Investor Profile

• Understands & cares about clinical outcomes• Qualifies as an “accredited investor”• Seeks high growth investment opportunities• Appreciates the underlying risks• Committed to a portfolio approach

Page 13: Healthcare Investment Portal - d1luhn51essjf9.cloudfront.net · Healthcare Investment Portal Capitalizing Breakthrough Innovations Accredited investors lack access to the most compelling

If You’re Interested

• Register on our portal www.venturehealth.com• Review the deals when they become available• Conduct due diligence, with our help• Understand that there is no guarantee of returns• Plan to invest in a portfolio of companies, to diversify risk

13

Page 14: Healthcare Investment Portal - d1luhn51essjf9.cloudfront.net · Healthcare Investment Portal Capitalizing Breakthrough Innovations Accredited investors lack access to the most compelling

Andrew [email protected]

(510) 290‐0643

Talat [email protected]

(650) 823‐1830

Thank You

Mir [email protected]

(415) 515‐2550

Mar [email protected]

(650) 485‐3867